Penserra Capital Management’s Biogen BIIB Stock Holding History

Penserra Capital Management’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2K	Hold	12	–	–	﹤0.01%	1024
2026 Q1	$2K	Hold	12	–	–	﹤0.01%	993
2025 Q4	$2K	Sell	12 -5,033	-100%	-$822K	﹤0.01%	966
2025 Q3	$706K	Buy	5,045 +5,033	+41,942%	+$680K	0.01%	492
2025 Q2	$1K	Hold	12	–	–	﹤0.01%	976
2025 Q1	$1K	Sell	12 -370	-97%	-$52.9K	﹤0.01%	1005
2024 Q4	$57K	Buy	382 +370	+3,083%	+$62.4K	﹤0.01%	918
2024 Q3	$2K	Hold	12	–	–	﹤0.01%	1007
2024 Q2	$3K	Hold	12	–	–	﹤0.01%	1102
2024 Q1	$2K	Sell	12 -659	-98%	-$154K	﹤0.01%	1133
2023 Q4	$173K	Sell	671 -189	-22%	-$46.4K	﹤0.01%	784
2023 Q3	$220K	Sell	860 -134	-13%	-$35.8K	﹤0.01%	717
2023 Q2	$282K	Buy	994 +926	+1,362%	+$276K	0.01%	682
2023 Q1	$18K	Sell	68 -10	-13%	-$2.77K	﹤0.01%	897
2022 Q4	$21K	Sell	78 -58	-43%	-$16.4K	﹤0.01%	942
2022 Q3	$36K	Buy	136 +112	+467%	+$23.8K	﹤0.01%	838
2022 Q2	$4K	Sell	24 -8	-25%	-$1.64K	﹤0.01%	1357
2022 Q1	$6K	Sell	32 -46	-59%	-$10K	﹤0.01%	1431
2021 Q4	$18K	Buy	78 +24	+44%	+$6.17K	﹤0.01%	1242
2021 Q3	$15K	Buy	54 +4	+8%	+$1.31K	﹤0.01%	1291
2021 Q2	$17K	Buy	+50	New	+$15.1K	﹤0.01%	1181
2016 Q4	–	Sell	-589	Closed	-$184K	–	920
2016 Q3	$184K	Buy	+589	New	+$174K	0.02%	166
2016 Q1	–	Sell	-20	Closed	-$6K	–	982
2015 Q4	$6K	Buy	+20	New	+$5.75K	﹤0.01%	688

Other funds holding BIIB

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Penserra Capital Management's BIIB Position: Q2 2026 in Review

Penserra Capital Management held its Biogen (BIIB) position steady in Q2 2026 at 12 shares worth $2K. The position accounts for ﹤0.01% of the portfolio, ranked #1024.

Penserra Capital Management first reported a position in BIIB in Q4 2015 and has held it in 23 quarters since. The position peaked at $706K in Q3 2025. 1,041 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

Penserra Capital Management held 12 shares of Biogen worth $2K as of Q2 2026.
Penserra Capital Management left its Biogen share count unchanged in Q2 2026.
Biogen made up ﹤0.01% of Penserra Capital Management's portfolio in Q2 2026, its #1024 holding.
Penserra Capital Management first reported a position in Biogen in Q4 2015 and has held it in 23 quarters since.
Penserra Capital Management's Biogen position peaked at $706K in Q3 2025.
1,041 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Penserra Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.